Susquehanna Fundamental Investments’s Wave Life Sciences WVE Stock Holding History

Susquehanna Fundamental Investments’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-36,089	Closed	-$235K	–	781
2025 Q2	$235K	Sell	36,089 -57,134	-61%	-$377K	0.01%	649
2025 Q1	$753K	Buy	+93,223	New	+$1.02M	0.01%	758
2024 Q2	$93.5K	Sell	18,744 -46,821	-71%	-$267K	﹤0.01%	900
2024 Q1	$405K	Buy	+65,565	New	+$328K	0.02%	500
2020 Q4	–	Sell	-29,903	Closed	-$254K	–	1625
2020 Q3	$254K	Sell	29,903 -22,461	-43%	-$246K	0.01%	1118
2020 Q2	$545K	Buy	+52,364	New	+$493K	0.03%	597

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Susquehanna Fundamental Investments's WVE Position: Q3 2025 in Review

Susquehanna Fundamental Investments sold out of Wave Life Sciences (WVE) in Q3 2025, closing a stake of 36,089 shares — an estimated $235K sold.

Susquehanna Fundamental Investments first reported a position in WVE in Q2 2020 and held it in 6 quarters. The position peaked at $753K in Q1 2025. 189 funds tracked by Wall St. Rank hold WVE as of Q3 2025.

Susquehanna Fundamental Investments reported no remaining Wave Life Sciences position as of Q3 2025 after selling out during the quarter.
Susquehanna Fundamental Investments sold 36,089 Wave Life Sciences shares in Q3 2025, an estimated $235K.
Susquehanna Fundamental Investments first reported a position in Wave Life Sciences in Q2 2020 and held it in 6 quarters.
Susquehanna Fundamental Investments's Wave Life Sciences position peaked at $753K in Q1 2025.
189 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q3 2025, filed 14 Nov 2025.